State Street’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

State Street’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-951,871	Closed	-$19M	–	4984
2022 Q3	$19M	Buy	951,871 +30,146	+3%	+$398K	﹤0.01%	2268
2022 Q2	$6.35M	Sell	921,725 -1,880,424	-67%	-$13.2M	﹤0.01%	2976
2022 Q1	$26.1M	Buy	2,802,149 +999,479	+55%	+$10.6M	﹤0.01%	2204
2021 Q4	$25.6M	Buy	1,802,670 +344,670	+24%	+$5.96M	﹤0.01%	2288
2021 Q3	$33.8M	Sell	1,458,000 -716,375	-33%	-$16.9M	﹤0.01%	2095
2021 Q2	$54.1M	Buy	2,174,375 +302,780	+16%	+$8.14M	﹤0.01%	1784
2021 Q1	$52.4M	Buy	1,871,595 +1,016,220	+119%	+$36.7M	﹤0.01%	1718
2020 Q4	$29.9M	Buy	855,375 +645,047	+307%	+$28.1M	﹤0.01%	1983
2020 Q3	$10.5M	Buy	+210,328	New	+$8.5M	﹤0.01%	2415

State Street's FMTX Position: Q4 2022 in Review

State Street sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 951,871 shares — an estimated $19M sold.

State Street first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $54.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

State Street reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
State Street sold 951,871 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $19M.
State Street first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
State Street's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $54.1M in Q2 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.